I recently used the services of a company for my research needs. The website was easy to use and the products were of good quality. The customer service team was helpful and responsive. I would definitely recommend them to others.
Questions about Transbiomed
What is Transbiomed?
Transbiomed is a Barcelona, Spain-based biotechnology company that developed a urine test for early prostate cancer diagnosis. The company aims to use this device as an alternative to biopsy to determine the existence of this type of cancer. They intend to begin clinical validation of their innovations in different Spanish hospitals and target to start commercializing the device by 2013.
Where is Transbiomed located and what are the key features of their website?
The company is located in Barcelona, Spain. They have a user-friendly website and their customer service team is knowledgeable. The website provides all the necessary information and their products have always met expectations.
How is Transbiomed rated on Trustburn?
On Trustburn, Transbiomed has a rating of 3.9 out of 5 based on 10 reviews.
AI-generated from reviews on this page. Verify anything important with the company directly.
I recently used a company's services and found them to be satisfactory. The website was easy to navigate and the customer service team was responsive. I would recommend them to others.
👍 Transbiomed has exceeded my expectations. The quality of their products is outstanding and their customer service is top-notch. I am extremely happy with the excellent service I received from them. Highly recommend!
I had a positive experience using Transbiomed's services. The quality of their products was good and the customer service team was helpful. Overall, I am happy with their service.
I have been a customer of Transbiomed for about a year now and I must say they provide excellent service. Their website is user-friendly and easy to navigate. The information about their products is detailed and well-organized. I have always received prompt responses to my inquiries and the staff is very knowledgeable and helpful. The quality of their products is top-notch and they always deliver on time. Overall, I am extremely satisfied with Transbiomed and would highly recommend them to anyone in need of their services.
👍 Transbiomed has provided exceptional service. Their products are reliable and their customer service is top-notch. I am highly satisfied with my experience and would recommend them to others in the field.
Transbiomed has been a reliable partner for my research needs. Their website provides all the necessary information and their products have always met my expectations. The customer service team is knowledgeable and responsive. I highly recommend Transbiomed for anyone in the biomedical field.
I recently used the services of a company whose website is transbiomed.net. I was pleasantly surprised by the level of professionalism and quality they provided. The process was smooth and efficient, and the customer service was excellent. I would definitely recommend them to others.
I have been using Transbiomed for a while now and I must say that their products are of great quality. The company has a user-friendly website and their customer service is reliable. I am satisfied with my overall experience.
Transbiomed has been a reliable supplier of biomedical products. Their website is user-friendly and their customer service team is knowledgeable. I have had a positive experience with them and would recommend their services.
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About Transbiomed
Transbiomed is a Barcelona, Spain-based biotechnolgy company. The company, has developed a urine test that allows early diagnosis of prostate cancer and intends to use the funding to begin clinical validation of its innovations in different Spanish hospitals. Transbiomed aims to propose the device as an alternative to biopsy to determine the existence of this type of cancer. The target is to start commercializing the device by 2013.
- Website
- transbiomed.net